Financings In Brief: ImmuLogic
Executive Summary
ImmuLogic: Registers with SEC for 2 mil. share common, secondary offering. Hambrecht & Quist, UBS Securities and Vector Securities International will manage the offering, and they have the option to purchase up to an additional 300,000 shares to cover over-allotments if there are any, the Waltham, Mass.-based allergy products firm notes. The company announced Aug. 24 that it had sold 1 mil. shares of common stock at $10 per share to Amerindo Investment Advisors in a public offering. Amerindo is a long-time investor in the company. With that offering, ImmuLogic had approximately 17.1 mil. shares outstanding and approximately $65 mil. in cash on hand...